HSK39004
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HSK39004, covering 2025-05-14 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients [Phase 2]